Replies to post #221127 on Biotech Values

[DewDiligence]

ANIX -23% on delay filing IND for CAR-T so that more manufacturing “optimization” can be conducted:

https://www.prnewswire.com/news-releases/anixa-biosciences-provides-update-on-car-t-program-300974423.html